Related Experiment Video
Updated: Dec 21, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The severe cardiorenal syndrome: 'Guyton revisited'
Lennart G Bongartz1, Maarten Jan Cramer, Pieter A Doevendans
1Department of Cardiology, Heart-Lung Centre Utrecht, Utrecht, The Netherlands.
Insights
The severe cardiorenal syndrome (SCRS) describes how combined heart and kidney failure worsens both conditions, leading to significantly higher cardiovascular risks. Understanding these interconnected cardiorenal pathways is crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Pathophysiology
Background:
- Increasing incidence of cardiac failure and chronic renal failure.
- Co-existence of cardiac and renal failure presents a poor prognosis.
- Existing hemodynamic models do not fully explain accelerated atherosclerosis and organ decline.
Purpose of the Study:
- Propose the severe cardiorenal syndrome (SCRS) as a distinct pathophysiological entity.
- Explore interactions between cardiorenal connectors in SCRS.
- Elucidate the network of positive feedback loops in SCRS.
Main Methods:
- Review of existing physiological frameworks (e.g., Guyton's model).
- Analysis of key pathophysiological components: renin-angiotensin system, oxidative stress, inflammation, sympathetic nervous system.
- Conceptual modeling of cardiorenal interactions.
Main Results:
- Combined cardiac and renal dysfunction amplifies organ failure progression.
- Cardiovascular morbidity and mortality are significantly elevated in SCRS patients.
- Identified interactions between renin-angiotensin system, oxidative stress, inflammation, and sympathetic nervous system.
Conclusions:
- SCRS is characterized by amplified progression of cardiac and renal failure.
- Positive feedback loops among cardiorenal connectors form the basis of SCRS.
- Further research into these interactions is warranted to improve management strategies.
Abstract:
The incidence of cardiac failure and chronic renal failure is increasing and it has now become clear that the co-existence of the two problems has an extremely bad prognosis. We propose the severe cardiorenal syndrome (SCRS), a pathophysiological condition in which combined cardiac and renal dysfunction amplifies progression of failure of the individual organ, so that cardiovascular morbidity and mortality in this patient group is at least an order of magnitude higher than in the general population. Guyton has provided an excellent framework describing the physiological relationships between cardiac output, extracellular fluid volume control, and blood pressure. While this model is also sufficient to understand systemic haemodynamics in combined cardiac and renal failure, not all aspects of the observed accelerated atherosclerosis, structural myocardial changes, and further decline of renal function can be explained. Since increased activity of the renin-angiotensin system, oxidative stress, inflammation, and increased activity of the sympathetic nervous system seem to be cornerstones of the pathophysiology in combined chronic renal disease and heart failure, we have explored the potential interactions between these cardiorenal connectors. As such, the cardiorenal connection is an interactive network with positive feedback loops, which, in our view, forms the basis for the SCRS.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
10:25Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
Published on: August 30, 2011
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...